Sphera Funds Management Ltd. Catalyst Pharmaceuticals, Inc. Transaction History

Sphera Funds Management Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$13.18 - $17.11 $3.8 Million - $4.93 Million	288,000 New	288,000 $4.59 Million
Q3 2020 Nov 12, 2020	SELL	$2.97 - $5.08 $2.17 Million - $3.71 Million	-730,557 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$3.48 - $5.05 $2.54 Million - $3.69 Million	730,557 New	730,557 $3.38 Million
Q1 2018 May 10, 2018	SELL	$2.39 - $4.01 $1.38 Million - $2.31 Million	-576,825 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$2.51 - $4.4 $1.45 Million - $2.54 Million	576,825	576,825 $2.26 Million

348

98.5M

13.4K

11.7K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.27B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.